Should I still rely on Prospect Capital management in May 2019?

  3 days ago at Macroaxis 
By Vlad Skutelnik
In this article I will go over Prospect Capital. I will look into some reasons why it is still possible for the company to generate above average margins and lots of cash flow. This firm Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, Prospect Capital is expected to generate 40.47 times less return on investment than the market. In addition to that, ... [more]
 risk ideas   prospect capital financial services asset management
PROSPECT CAPITAL currently holds roughly 109.67M in cash with 224.04M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3. Prospect Capital dividends can provide a clue to current valuation of the stock. The firm one year expected dividend income is about $0.16 per share. The company has Profit Margin (PM) of 25.89 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large.
Prospect Capital
  few days ago at Macroaxis 
By Vlad Skutelnik
This article is aimed at all current or potential Prospect Capital investors. I will look into why albeit cyclical Prospect Capital disturbance, the long term basic indicators of the company are still strong. This firm Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, Prospect Capital is expected to under-perform the market. In addition to that, the company is 1.21 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The market is currently generating roughly 0.18 per unit of volatility. Prospect Capital holds recent Real Value of $7.37775 per share. The prevailing price of the company is $6.65. At this time the company appears to be undervalued. Macroaxis determines value of Prospect Capital from analyzing the company fundamentals such as Return On Equity of 5.49%, Current Valuation of 4.88B and Shares Owned by Insiders of 17.41% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
 risk ideas   prospect capital financial services asset management
Peoples United Finan
  few days ago at Macroaxis 
By Vlad Skutelnik
This talk is geared to all Peoples United leadership as well as to investors considering exiting their position in the firm. I will break down why Peoples United leadership may should not consider a stake in the firm. The company Piotroski F Score is 6 - Healthy. Given the investment horizon of 30 days, Peoples United is expected to under-perform the market. In addition to that, the company is 1.93 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The market is currently generating roughly 0.18 per unit of volatility. We found thirty-two available financial ratios for Peoples United Finan which can be compared to its competitors. To make sure the equity is not overpriced, please check all Peoples United Finan fundamentals including its Debt to Equity, and the relationship between Gross Profit and Price to Earnings To Growth . Given that Peoples United Finan has Number of Shares Shorted of 26.71M, we recommend you check out Peoples United Finan recent market performance to make sure the company can sustain itself down the road. Use Peoples United to protect your portfolios against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Peoples United to be traded at $16.62 in 30 days.
 risk ideas   peoples united financial services banks - regional - us banking
Alger Health Sciences
  few days ago at Macroaxis 
By Achuva Shats
This article is geared to all Alger Health investors as well as to investors considering exiting their position in the fund. I will inspect why investors should continue to be optimistic in the fund outlook. Alger Health Sciences chance of financial distress is under 1.00 % . Assuming 30 trading days horizon, Alger Health is expected to under-perform the market. In addition to that, the company is 1.94 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The market is currently generating roughly 0.19 per unit of volatility. Macroaxis considers Alger Health to be not too volatile. Alger Health Sciences secures Sharpe Ratio (or Efficiency) of -0.0662 which signifies that the fund had -0.0662% of return per unit of standard deviation over the last 1 month. Macroaxis philosophy in foreseeing risk of any fund is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Alger Health Sciences C exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Alger Health Sciences Mean Deviation of 0.9292 and Risk Adjusted Performance of 0.0175 to double-check risk estimate we provide.
 risk ideas   alger health alger health
STMicroelectronics N
  over a week ago at Macroaxis 
By Vlad Skutelnik
In this post I will go over STMicroelectronics. I will look into why we are still optimistic in anticipation of a recovery. STMicroelectronics N chance of financial distress is under 12.00 % . Assuming 30 trading days horizon, STMicroelectronics is expected to generate 5.11 times more return on investment than the market. However, the company is 5.11 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The market is currently generating roughly 0.19 per unit of risk. STMicroelectronics N has current Real Value of €15.3187 per share. The regular price of the company is €16.06. At this time the company appears to be overvalued. Macroaxis measures value of STMicroelectronics N from evaluating the company fundamentals such as Return On Equity of 21.75% and Shares Outstanding of 894.32M as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point in time securities prices and their ongoing real values will draw towards each other.
 risk ideas   stmicroelectronics electrical, electronic electronic components technology semiconductors
NXP Semiconductors
  over two weeks ago at Macroaxis 
By Achuva Shats
This piece will concentrate on NXP Semiconductors. I will analyze why NXP Semiconductors investors may still consider a stake in the business. This firm Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, NXP Semiconductors is expected to generate 4.21 times more return on investment than the market. However, the company is 4.21 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The market is currently generating roughly 0.24 per unit of risk. We found thirty-seven available fundamentals for NXP Semiconductors which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all NXP Semiconductors N V fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that NXP Semiconductors has Price to Earning of 14.61X, we recommend you check NXP Semiconductors last-minute market performance to make sure the company can sustain itself for the next two years. Use NXP Semiconductors to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of NXP Semiconductors to be traded at $102.68 in 30 days.
 risk ideas   nxp semiconductors technology semiconductors electronic equipment
US Ecology
  over two weeks ago at Macroaxis 
By Ellen Johnson
Today's write-up is for all stakeholders who are seriously contemplating on exiting a position in US Ecology. I will summarize the rationale of why US Ecology stakeholders should not be insulted by the new pull out. US Ecology Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, US Ecology is expected to under-perform the market. In addition to that, the company is 2.98 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The market is currently generating roughly 0.24 per unit of volatility. What is US Ecology Target Price Odds to finish over Current Price? Out from normal probability distribution, the odds of US Ecology to move above current price in 30 days from now is about 53.65%. The US Ecology probability density function shows the probability of US Ecology Stock to fall within a particular range of prices over 30 days . Given the investment horizon of 30 days, US Ecology has beta of 0.7643 suggesting as returns on market go up, US Ecology average returns are expected to increase less than the benchmark. However during bear market, the loss on holding US Ecology will be expected to be much smaller as well. Additionally, the company has a negative alpha implying that the risk taken by holding this equity is not justified. US Ecology is significantly underperforming S&P 500.
 risk ideas   us ecology industrials waste management
Amazon
  over two weeks ago at Macroaxis 
By Ellen Johnson
Today I will outline Amazon. I will evaluate if Amazon shares are reasonably priced going into May. The company Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, Amazon is expected to generate 1.98 times more return on investment than the market. However, the company is 1.98 times more volatile than its market benchmark. It trades about 0.29 of its potential returns per unit of risk. The market is currently generating roughly 0.24 per unit of risk. What is Amazon Target Price Odds to finish over Current Price? Proceeding from normal probability distribution, the odds of Amazon to move above current price in 30 days from now is about 5.27%. The Amazon probability density function shows the probability of Amazon Stock to fall within a particular range of prices over 30 days . Given the investment horizon of 30 days, the stock has beta coefficient of 1.4823 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average . However, if the benchmark returns are expected to be negative, Amazon will likely underperform. Additionally, the company has an alpha of 0.09 implying that it can potentially generate 0.09% excess return over S&P 500 after adjusting for the inherited market risk (beta).
 risk ideas   amazon consumer cyclical specialty retail retail
Westamerica Bancorporation
  over two weeks ago at Macroaxis 
By Achuva Shats
Today article will go over Westamerica Bancorporation. I will analyze why it could be a much better year for Westamerica Bancorporation shareholders. Westamerica Bancorporation Piotroski F Score is 5 - Healthy. Given the investment horizon of 30 days, Westamerica Bancorporation is expected to under-perform the market. In addition to that, the company is 2.11 times more volatile than its market benchmark. It trades about -0.01 of its total potential returns per unit of risk. The market is currently generating roughly 0.24 per unit of volatility. We found thirty-three available indicators for Westamerica Bancorporation which can be compared to its rivals. To make sure the equity is not overpriced, please check out all Westamerica Bancorporation fundamentals including its Revenue, Debt to Equity, Number of Employees, as well as the relationship between Cash and Equivalents and Short Ratio . Given that Westamerica Bancorporation has Number of Shares Shorted of 2.78M, we strongly advise you confirm Westamerica Bancorporation prevalent market performance to make sure the company can sustain itself down the road. Use Westamerica Bancorporation to protect your portfolios against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Westamerica Bancorporation to be traded at $60.28 in 30 days.
 risk ideas   westamerica bancorporation financial services banks - regional - us
Microsoft
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
This story will review Microsoft. I will analyze why it could be a much better year for Microsoft shareholders. This firm Piotroski F Score is 4 - Ordinary. Given the investment horizon of 30 days, Microsoft is expected to generate 1.5 times more return on investment than the market. However, the company is 1.5 times more volatile than its market benchmark. It trades about 0.31 of its potential returns per unit of risk. The market is currently generating roughly 0.24 per unit of risk. We found thirty-eight available fundamentals for Microsoft which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Microsoft Corporation fundamentals including its Cash per Share, Beta and the relationship between Revenue and Cash Flow from Operations . Given that Microsoft has Price to Earning of 27.81X, we recommend you check Microsoft last-minute market performance to make sure the company can sustain itself down the road. Use Microsoft to protect your portfolios against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Microsoft to be traded at $116.89 in 30 days.
 risk ideas   microsoft technology software - infrastructure business services

Share Stories

Syndicate Stories to major social sites

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Search macroaxis.com